563 related articles for article (PubMed ID: 25890584)
1. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
[TBL] [Abstract][Full Text] [Related]
2. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
[TBL] [Abstract][Full Text] [Related]
3. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
4. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
[TBL] [Abstract][Full Text] [Related]
5. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.
Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
J Cardiovasc Magn Reson; 2014 May; 16(1):36. PubMed ID: 24886708
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study.
Mayr A; Kitterer D; Latus J; Steubing H; Henes J; Vecchio F; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H; Greulich S
J Cardiovasc Magn Reson; 2016 Oct; 18(1):67. PubMed ID: 27733210
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
[TBL] [Abstract][Full Text] [Related]
8. Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.
Ide S; Riesenkampff E; Chiasson DA; Dipchand AI; Kantor PF; Chaturvedi RR; Yoo SJ; Grosse-Wortmann L
J Cardiovasc Magn Reson; 2017 Feb; 19(1):10. PubMed ID: 28143545
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.
Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC
J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370
[TBL] [Abstract][Full Text] [Related]
10. Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation.
Cui Y; Cao Y; Song J; Dong N; Kong X; Wang J; Yuan Y; Zhu X; Yan X; Greiser A; Shi H; Han P
J Cardiovasc Magn Reson; 2018 Apr; 20(1):25. PubMed ID: 29681243
[TBL] [Abstract][Full Text] [Related]
11. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis.
Zagrosek A; Abdel-Aty H; Boyé P; Wassmuth R; Messroghli D; Utz W; Rudolph A; Bohl S; Dietz R; Schulz-Menger J
JACC Cardiovasc Imaging; 2009 Feb; 2(2):131-8. PubMed ID: 19356545
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy.
Sunthankar SD; George-Durrett K; Crum K; Slaughter JC; Kasten J; Raucci FJ; Markham LW; Soslow JH
J Cardiovasc Magn Reson; 2023 Jul; 25(1):44. PubMed ID: 37517994
[TBL] [Abstract][Full Text] [Related]
13. CMR Native T1 Mapping Allows Differentiation of Reversible Versus Irreversible Myocardial Damage in ST-Segment-Elevation Myocardial Infarction: An OxAMI Study (Oxford Acute Myocardial Infarction).
Liu D; Borlotti A; Viliani D; Jerosch-Herold M; Alkhalil M; De Maria GL; Fahrni G; Dawkins S; Wijesurendra R; Francis J; Ferreira V; Piechnik S; Robson MD; Banning A; Choudhury R; Neubauer S; Channon K; Kharbanda R; Dall'Armellina E
Circ Cardiovasc Imaging; 2017 Aug; 10(8):e005986. PubMed ID: 28798137
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.
Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC
J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686
[TBL] [Abstract][Full Text] [Related]
15. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
Karamitsos TD; Piechnik SK; Banypersad SM; Fontana M; Ntusi NB; Ferreira VM; Whelan CJ; Myerson SG; Robson MD; Hawkins PN; Neubauer S; Moon JC
JACC Cardiovasc Imaging; 2013 Apr; 6(4):488-97. PubMed ID: 23498672
[TBL] [Abstract][Full Text] [Related]
16. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
[TBL] [Abstract][Full Text] [Related]
17. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
[TBL] [Abstract][Full Text] [Related]
18. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in myocardial and skeletal muscles in idiopathic inflammatory cardiomyopathy.
Xu Y; Sun J; Wan K; Yu L; Wang J; Li W; Yang F; Sun J; Cheng W; Mui D; Zhang Q; Xie Q; Chen Y
J Cardiovasc Magn Reson; 2020 Apr; 22(1):22. PubMed ID: 32272936
[TBL] [Abstract][Full Text] [Related]
20. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
